维普中文期刊产品整合服务
55篇 您的检索式:作者名="Seufferlein"
    题名 作者 年代 出处 被引量
1Hepatobiliary complications of alveolar echinococcosis: A long-term follow-up study显示文摘AIM:To determine the long-term hepatobiliary complications of alveolar echinococcosis(AE) and treatment options using interventional methods.METHODS:Included in the study were 35 patients with AE enrolled in the Echinococcus Multilocularis Data Bank of the University Hospital of Ulm.Patients underwent endoscopic intervention for treatment of hepatobiliary complications between 1979 and 2012.Patients' epidemiologic data, clinical symptoms, and indications for the intervention, the type of intervention and any additional procedures, hepatic laboratory parameters(pre- and post-intervention), medication and surgical treatment(pre- and post-intervention), as well as complications associated with the intervention and patients‘ subsequent clinical courses were analyzed.In order to compare patients with AE with and without history of intervention, data from an additional 322 patients with AE who had not experienced hepatobiliary complications and had not undergone endoscopic intervention were retrieved and analyzed.RESULTS:Included in the study were 22 male and 13 female patients whose average age at first diagnosis was 48.1 years and 52.7 years at the time of intervention.The average time elapsed between first diagnosis and onset of hepatobiliary complications was 3.7 years.The most common symptoms were jaundice, abdominal pains, and weight loss.Thenumber of interventions per patient ranged from one to ten.Endoscopic retrograde cholangiopancreatography(ERCP)was most frequently performed in combination with stent placement(82.9%),followed by percutaneous transhepatic cholangiodrainage(31.4%)and ERCP without stent placement(22.9%).In 14.3%of cases,magnetic resonance cholangiopancreatography was performed.A total of eight patients received a biliary stent.A comparison of biochemical hepatic function parameters at first diagnosis between patients who had or had not undergone intervention revealed that these were significantly elevated in six patients who had undergone intervention.Complications(cholangitis,pancreatitis)occurred in six patients during and in 12patients following the intervention.The average survival following onset of hepatobiliary complications was 8.8years.CONCLUSION:Hepatobiliary complications occur in about 10%of patients.A significant increase in hepatic transaminase concentrations facilitates the diagnosis.Interventional methods represent viable management options.Tilmann Graeter Franziska Ehing Suemeyra Oeztuerk Richard Andrew Mason Mark Martin Haenle Wolfgang Kratzer Thomas Seufferlein Beate Gruener 2015World Journal of Gastroenterology2015,21,16:6
2S3-Leitlinie ?Exokrines Pankreaskarzinom” 2007显示文摘G Adler T Seufferlein S Bischoff H.-J Brambs S Feuerbach G Grabenbauer S Hahn V Heinemann W Hohenberger J Langrehr M Lutz O Micke H Neuhaus P Neuhaus H Oettle P Schlag R Schmid W Schmiegel K Schlottmann J Werner B Wiedenmann I Kopp 2007Z Gastroenterol2007,,06:1
3Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells显示文摘Martin Steinkamp Irmlind Geerling Thomas Seufferlein Georg von Boyen Bernhard Egger Johannes Grossmann Leopold Ludwig Guido Adler Max Reinshagen 2003Gastroenterology2003,,:1
4Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells显示文摘 Seckl MJ Schwam E 2002Br J Cancer2002,86,7:1
5Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells显示文摘Withers DJ Coppock HA Seufferlein T 1996FEBS Lett1996,378,:1
6Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer:a prospective multi-center biomarker-oriented phase Ⅱ study显示文摘Moehler M Mueller A Trarbach T Lordick F Seufferlein T Kubicka S 2011Ann Oncol2011,22,:1
7Glial - derived neurotrophic factor regulates apoptosis in colonic epithelial cells 显示文摘Steinkamp M Geerling I Seufferlein T 2003Gastroenterology2003,124,7:1
8Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells显示文摘Seufferlein T Seckl M J Schwarz E 2002Br J Cancer2002,86,7:1
9Adrenomedullin stimulates DNA synthesis and cell proliferasion via elevation of cAMP in Swiss 3T3 cells显示文摘Withers DJ Coppock HA Seufferlein T 1996FEBS Lett1996,378,1:1
10Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity显示文摘Zhou S Bachem MG Seufferlein T 2008Cell Signal2008,20,4:1
11Molecular mechanisms of low intensity pulsed ultrasound inhuman skin fibroblasts显示文摘Zhou S Schmelz A Seufferlein T 2004Biol Chem2004,279,54:1
12Mechanisms of nordihydroguaiaretic acid - induced growth inhibition and apoptosis in human cancer cell显示文摘 Seckl M J Schwarz E 2002Br J Cancer2002,86,7:1
13Regorafenib 显示文摘Ettrich TJ Seufferlein T 2014Recent Results CaneerRes2014,2111,:1
14Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells显示文摘Tobias Busch Milena Armacki Tim Eiseler Golsa Joodi Claudia Temme Julia Jansen G?tz von Wichert M. Bishr Omary Joachim Spatz Thomas Seufferlein 2012Journal of Cell Science2012,,9:1
15Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells显示文摘Withers D J Coppock H A Seufferlein T Smith D M Bloom S R Rozengurt E 1996FEBS Lett1996,378,:1
16Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells显示文摘SEUFFERLEIN T SECKL MJ SCHWARZ E 2002Br J Cancer2002,86,7:1
17Mechanisms of nordihydroguaiaretic acid -induced growth inhibition and apoptosis in human cancer cell显示文摘Seufferlein T Seckl MJ Schwarz E 2002Br J Cancer2002,86,7:1
18Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells 显示文摘Steinkamp M Geerling I Seufferlein T 2003Gastroenterology2003,124,7:1
19Adrenomedullin stimulates DNA sythesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells显示文摘Withers DJ Coppock HA Seufferlein T 1996FEBS Lett1996,378,1:1
20Cetuximab with irinotecan/folinic acid/5-FU as first-line treatment in advanced gastric cancer:a nonrandomized multicenter AIO phase Ⅱ study显示文摘Kanzler S Trarbach T Seufferlein T 2009J Clin Oncol2009,27,15:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费